New insights into atypical Alzheimer's disease in the era of biomarkers
Most patients with Alzheimer's disease present with amnestic problems; however, a
substantial proportion, over-represented in young-onset cases, have atypical phenotypes …
substantial proportion, over-represented in young-onset cases, have atypical phenotypes …
Alzheimer's disease
JAS Lopez, HM González, GC Léger - Handbook of clinical neurology, 2019 - Elsevier
Alzheimer's disease (AD) dementia refers to a particular onset and course of cognitive and
functional decline associated with age together with a particular neuropathology. It was first …
functional decline associated with age together with a particular neuropathology. It was first …
Aducanumab: appropriate use recommendations
Aducanumab has been approved by the US Food and Drug Administration for treatment of
Alzheimer's disease (AD). Clinicians require guidance on the appropriate use of this new …
Alzheimer's disease (AD). Clinicians require guidance on the appropriate use of this new …
Alzheimer disease in African American individuals: increased incidence or not enough data?
LL Barnes - Nature Reviews Neurology, 2022 - nature.com
Research on racial differences in Alzheimer disease (AD) dementia has increased in recent
years. Older African American individuals bear a disproportionate burden of AD and …
years. Older African American individuals bear a disproportionate burden of AD and …
Effect of race on prediction of brain amyloidosis by plasma Aβ42/Aβ40, phosphorylated tau, and neurofilament light
Background and Objectives To evaluate whether plasma biomarkers of amyloid
(Aβ42/Aβ40), tau (p-tau181 and p-tau231), and neuroaxonal injury (neurofilament light …
(Aβ42/Aβ40), tau (p-tau181 and p-tau231), and neuroaxonal injury (neurofilament light …
[HTML][HTML] Culture, ethnicity, and level of education in Alzheimer's disease
M Rosselli, IV Uribe, E Ahne, L Shihadeh - Neurotherapeutics, 2023 - Elsevier
Alzheimer's disease (AD) is the most frequent cause of dementia, where the abnormal
accumulation of beta-amyloid (Aβ) and tau lead to neurodegeneration as well as loss of …
accumulation of beta-amyloid (Aβ) and tau lead to neurodegeneration as well as loss of …
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
CR Jack Jr, JS Andrews, TG Beach… - Alzheimer's & …, 2024 - Wiley Online Library
Abstract The National Institute on Aging and the Alzheimer's Association convened three
separate work groups in 2011 and single work groups in 2012 and 2018 to create …
separate work groups in 2011 and single work groups in 2012 and 2018 to create …
Racial and ethnic differences in amyloid PET positivity in individuals with mild cognitive impairment or dementia: a secondary analysis of the Imaging Dementia …
CH Wilkins, CC Windon, P Dilworth-Anderson… - JAMA …, 2022 - jamanetwork.com
Importance Racial and ethnic groups with higher rates of clinical Alzheimer disease (AD) are
underrepresented in studies of AD biomarkers, including amyloid positron emission …
underrepresented in studies of AD biomarkers, including amyloid positron emission …
Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation
Introduction Although dementia prevalence differs by race, it remains unclear whether
cognition and neuropsychiatric symptom severity differ between Black and White individuals …
cognition and neuropsychiatric symptom severity differ between Black and White individuals …
Assessment of racial/ethnic disparities in timeliness and comprehensiveness of dementia diagnosis in California
E Tsoy, RE Kiekhofer, EL Guterman, BL Tee… - JAMA …, 2021 - jamanetwork.com
Importance The US aging population is rapidly becoming more racially and ethnically
diverse. Early diagnosis of dementia is a health care priority. Objective To examine the …
diverse. Early diagnosis of dementia is a health care priority. Objective To examine the …